NovaBridge Biosciences
NBP · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $198 | $67 | $69 | $709 |
| - Cash | $165 | $54 | $68 | $79 |
| + Debt | $3 | $4 | $4 | $4 |
| Enterprise Value | $36 | $17 | $5 | $634 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$5 | -$12 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$3 | -$9 | -$20 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.069 | -0.28 | -0.11 | -0.25 |
| % Growth | 75.4% | -154.5% | 56% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |